PubMed=22427941; DOI=10.1371/journal.pone.0033041; PMCID=PMC3299721
Toriseva M., Ala-aho R., Peltonen S., Peltonen J., Grenman R., Kahari V.-M.
Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
PLoS ONE 7:e33041.1-e33041.16(2012)

PubMed=27305645; DOI=10.1111/exd.13109
Farshchian M., Nissinen L., Grenman R., Kahari V.-M.
Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2.
Exp. Dermatol. 26:89-92(2017)

PubMed=28322200; DOI=10.1016/j.ajpath.2017.01.006
Riihila P., Nissinen L., Farshchian M., Kallajoki M., Kivisaari A., Meri S., Grenman R., Peltonen S., Peltonen J., Pihlajaniemi T., Heljasvaara R., Kahari V.-M.
Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma.
Am. J. Pathol. 187:1186-1197(2017)

DOI=10.1158/1538-7445.AM2020-507
Kondratyev M.K., Pesic A., Dvorkin-Sheva A., Ketela T., Moffat J., Koritzinsky M., Wouters B.G.
Repurposing of FDA approved drugs for treatment of metastatic HNSCC.
Cancer Res. 80 Suppl. 16:507-507(2020)